Skip to content

Study the effect of intra ovarian Platalet-Rich Plasma (PRP) in treatment of depletion of ovarian reserve in women

Study the effect of Platalet-Rich Plasma (PRP) in treatment of depletion of ovarian reserve in women

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20151004024335N4
Enrollment
30
Registered
2019-05-20
Start date
2019-06-22
Completion date
Unknown
Last updated
2019-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infertility. Complication associated with artificial fertilization, unspecified

Interventions

Intervention group: 30 infertile women with poor responder ovary criteria. After getting informed consent, own of patient's blood derivatives (Platelet Rich Plasma
PRP) will be used. This product will be injected 1 time to patients..

Sponsors

Kerman University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 45 Years

Inclusion criteria

Inclusion criteria: Patients aged between 20-45 at least one ovary poor ovarian responders criteria including one of the following: Anti Mullerian Hormone <1.1 ng/mL; Antral follicle Count <7 follicles; History of Cancellation of the IVF Cycle due to the lack of follicle growth; IVF history with oocyte count less than 3.

Exclusion criteria

Exclusion criteria: IgA deficiency adhesion or severe damage to the pelvis or ovaries pregnancy anticoagulation therapy opium addiction gynecologic or non gynecologic malignancies chronic pelvic pain

Design outcomes

Primary

MeasureTime frame
Anti Mullerian Hormone. Timepoint: Before intervention and 1 and 6 months after intervention. Method of measurement: blood sample.

Secondary

MeasureTime frame
Antral follicle count. Timepoint: Before intervention and 1and 6 months after the intervention. Method of measurement: with trans vaginal ultrasonography.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactRobabe Hosseinisadat

Kerman University of Medical Sciences

robabehosseinisadat@yahoo.com+98 34 3132 8486

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026